| 1001/2267 | US=20 / Patologia Biddinger PW. Medullary carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LDR. Diagnostic pathology and molecular genetics of the thyroid. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 249-79. ISBN 978-0-7817-7459-8. CARCINOMA MEDULAR; HIPERPLASIA DE CELULAS C; CARCINOMA FOLICULAR; CARCINOMA PAPILIFERO |
| 1002/2267 | US=20 / Patologia Thompson LDR. Rare primary thyroid epithelial tumors. In: Nikiforov YE, Biddinger PW, Thompson LDR. Diagnostic pathology and molecular genetics of the thyroid. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 280-302. ISBN 978-0-7817-7459-8. CANCER DA TIREOIDE; CARCINOMA MUCOEPIDERMOIDE; CARCINOMA MUCOEPIDERMOIDE ESCLEROSANTE COM EOSINOFILIA; CARCINOMA DE CELULAS ESCAMOSAS; CARCINOMA MUCINOSO; CARCINOMA DA TIREOIDE COM DIFERENCIACAO SEMELHANTE A TIMO; TIMOMA |
| 1006/2267 | US=21 / Patologia Petersen RO, Sesterhenn IA, Davis CJ. Urethra. In: ___. Urologic pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 285-312. ISBN 978-0-7817-5343-2. URETRA. ANATOMIA; METAPLASIA NEFROGENICA; GONORREIA; URETRITE NAO-GONOCOCICA; TUBERCULOSE; CONDILOMA ACUMINADO; MALACOPLAQUIA; GRANULOMATOSE DE WEGENER; URETRITE INCRUSTADO; SARCOIDOSE; URETRITE POLIPOIDE; CARUNCULA; DIVERTICULO; ENDOMETRIOSE; AMILOIDOSE; POLIPOS FIBROEPITELIAIS; POLIPO URETERAL; PAPILOMA INVERTIDO; ADENOMA VILOSO; CARCINOMA DA URETRA; TUMOR CARCINOIDE; CARCINOMA NEUROENDOCRINO DE CELULAS PEQUENAS; CARCINOMA DA GLANDULA DE COWPER; CARCINOSSARCOMA; LINFOMA MALIGNO; PLASMACITOMA; FEOCROMOCITOMA; PARAGANGLIOMA |
| 1007/2267 | US=21 / Patologia Petersen RO, Sesterhenn IA, Davis CJ. Prostate. In: ___. Urologic pathology. 3rd ed. Philadelphia: Lippincott Willians & Wilkins, 2009. p. 451-559. ISBN 978-0-7817-5343-2. PROSTATA. ANATOMIA; PROSTATITE AGUDA; PROSTATITE CRONICA; PROSTATITE GRANULOMATOSE; MALAKOPLAKIA; SARCOIDOSE; GRANULOMATOSE DE WEGENER; ENDOMETRIOSE; AMILOIDOSE; HEMATOPOIESE EXTRAMEDULAR; INFARTO DA PROSTATA; ATROFIA; HIPERPLASIA; METAPLASIA; HIPERPLASIA NODULAR; HIPERPLASIA BENIGNA DA PROSTATA; HIPERPLASIA ADENOMATOSA ATIPICA; CANCER DE PROSTATA; CARCINOMA UROTELIAL |
| 1008/2267 | US=22 / Urologia Bukowski RM, Figlin RA, Motzer RJ. Targeted therapy for metastatic renal cell carcinoma: overview. In: ___. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 1-12. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; VHL GENE; PROTEINA VHL; VEGF; PDGF; TERAPIAS RCC |
| 1009/2267 | US=22 / Urologia Dhanani N, Vocke C, Bratslavsky G, Linehan WM. Molecular genetics in inherited renal cell carcinoma: identification of targets in the hereditary syndromes. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 13-33. ISBN 978-1-58829-737-2. NEOPLASIAS DE RIM; HIPPLE CON-LINDAU; BHD; BIRT-HOGG-DUBE; FUMARATO HIDRATASE |
| 1010/2267 | US=22 / Urologia Zhou M. Molecular targets in renal tumors: pathologic assessment. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 35-48. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; NEOPLASIA RENAL PATOLOGIA; CITOGENETICA; PROGNOSTICO |
| 1011/2267 | US=22 / Urologia Hutson TE, Thakkar S, Cohen P, Borden EC. Interferons and interleukin-2: molecular basis of activity and therapeutic results. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 49-78. ISBN 978-1-58829-737-2. INTERFERON; INTERLEUCINA; IFN-X2, IL-2; INIBICAO DA ANGIOGENESE; EFEITOS CLINICOS DA IL-2 E IFN |
| 1012/2267 | US=22 / Urologia Junior Kaelin WG, Geoge DJ. The molecular biology of kidney cancer and its clinical translation into treatment strategies. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 79-97. ISBN 978-1-58829-737-2. VON HIPPEL-LINDAU; HIPOXIA; ANGIOGENESE; HIF; VEGF; KDR; MTOR |
| 1013/2267 | US=22 / Urologia Rathmell WK, Rini BI. VEGF: biologic aspects and clinical approaches. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 99-118. ISBN 978-1-58829-737-2. |
| 1014/2267 | US=22 / Urologia Lam JS, Figlin RA, Belldegrum AS,. VEGF: and PDGF receptors: biologic relevance and clinical approaches to inhibition. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 119-49. ISBN 978-1-58829-737-2. DERIVADO DE PLAQUETAS FACTOR DE CRESCIMENTO; RECEPTORES; TRANSDUCAO DE SINAL; TIROSINA-QUINASE; FACTOR DE CRESCIMENTO ENDOTELIAL VASCULAR |
| 1015/2267 | US=22 / Urologia Motzer RJ. Sunitinib and axitinib in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 151-65. ISBN 978-1-58829-737-2. SUNITINIB; SU11248; AXITINIBE; CARCINOMA DE CELULAS RENAIS; SUTENT; AG-013736 |
| 1016/2267 | US=22 / Urologia George S, Bukowski RM. Sorafenib in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 167-87. ISBN 978-1-58829-737-2. CARCINOMA DE CELULAS RENAIS; SORAFENIB; INIBIDOR DE TIROSINA CINASE; VEGF; TERAPIA ANTIANGIOGENICA |
| 1017/2267 | US=22 / Urologia Rini BI. Additional tyrosine kinase inhibitors in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 189-93. ISBN 978-1-58829-737-2. INIBIDORES VEGF; TKI; PTK787; AZD2171; ZK222584; INIBIDOR DE TIROSINA CINASE; PAZOPANIB |
| 1018/2267 | US=22 / Urologia Ramakrishnan V, Bhaskar V, Fox M, Wilson K, Cheville JC, Finck BA. Integrin &*945;5&*946;1 as a noveltherapeutic target in renal cancer. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 195-209. ISBN 978-1-58829-737-2. INTEGRINAS NA ANGIOGENESE; TERAPIA ANTI-ANGIOGENICA; CANCER RENAL &*945;5&*946;1; VOLOCIXIMAB |
| 1019/2267 | US=22 / Urologia Shuch B, Belldegrun AS, Figlin RA. Carbonic anhydrase IX: biology and clinical approaches. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 211-29. ISBN 978-1-58829-737-2. CAIX; CCR CELULA CLARA; INTERLEUCINA-2 RESPOSTA; PROGNOSTICO; G250 |
| 1020/2267 | US=22 / Urologia Oosterwijk-Wakka JC, Boerman OC, Mulders PFA, Oosterwijk E. Monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma: biological and clinical studies. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 231-47. ISBN 978-1-58829-737-2. |